Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ShareHope Medicine CoROCO:8403 -0.26%71 EV-to-OCF is 7.60 as of Sep. 22, 2026, which is 43% below its 10-year median of 13.42. GuruFocus rates ROCO:8403 with a GF Score™ of 71/100 and a GF Value™ of NT$28.99 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 122 Medical Distribution companies, ShareHope Medicine Co ranks worse than 52.46% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, ShareHope Medicine Co's Enterprise Value is NT$3,251 Mil.
ShareHope Medicine Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was NT$428 Mil. Therefore, ShareHope Medicine Co's EV-to-OCF for today is 7.60.
The historical rank and industry rank for ShareHope Medicine Co's EV-to-OCF or its related term are showing as below:
ROCO:8403'
s EV-to-OCF Range Over the Past 10 Years
Min: 4.63 Med: 13.42 Max: 86.91
Current: 7.94
During the past 13 years, the highest EV-to-OCF of ShareHope Medicine Co was 86.91. The lowest was 4.63. And the median was 13.42.
ROCO:8403's EV-to-OCF is ranked worse than 52.46% of 122
companies
in the Medical Distribution industry
Industry Median: 7.61
vs ROCO:8403: 7.94
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
ShareHope Medicine Co (ROCO:8403) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
ShareHope Medicine Co's PE Ratio (TTM) for today is calculated as:
ShareHope Medicine Co's share price for today is NT$18.95.
ShareHope Medicine Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1.174.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, ShareHope Medicine Co's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ShareHope Medicine Co EV-to-OCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, ShareHope Medicine Co's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where ShareHope Medicine Co's EV-to-OCF falls into.
ShareHope Medicine Co's current Enterprise Value is NT$3,251 Mil.
ShareHope Medicine Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$428 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ShareHope Medicine Co (ROCO:8403) has a EV-to-OCF of 7.60 as of Sep. 22, 2026. This is 43% below median its historical median of 13.42. Over the past decade, ShareHope Medicine Co's EV-to-OCF has ranged from 4.63 to 86.91. According to the industry distribution chart, ShareHope Medicine Co ranks #64 out of 122 companies in the Medical Distribution industry, placing it in the top 52.5%.
Is ShareHope Medicine Co's EV-to-OCF too high?
ShareHope Medicine Co's current EV-to-OCF of 7.60 is 43% below median its 10-year median of 13.42. Over the past 10 years, this metric has ranged from a low of 4.63 to a high of 86.91. The Medical Distribution industry median EV-to-OCF is 7.61. ShareHope Medicine Co's value of 7.60 is 0.1% below this industry median. Based on the distribution chart, ShareHope Medicine Co ranks #64 out of 122 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, ShareHope Medicine Co has a GF Score™ of 71/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does ShareHope Medicine Co's EV-to-OCF compare to MCK and COR?
According to the Medical Distribution industry distribution chart, ShareHope Medicine Co ranks #64 out of 122 companies for EV-to-OCF. This places ShareHope Medicine Co in the lower half of its industry. The industry median EV-to-OCF is 7.61. ShareHope Medicine Co's value of 7.60 is 0.1% below this benchmark. Historically, ShareHope Medicine Co's own EV-to-OCF has ranged from 4.63 to 86.91 over the past decade. While the company's 10-year median is 13.42 vs. the industry median of 7.61, ShareHope Medicine Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Distribution company?
The median EV-to-OCF among Medical Distribution companies is 7.61, based on 122 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ShareHope Medicine Co's current EV-to-OCF of 7.60 is 0.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median EV-to-OCF is 7.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ShareHope Medicine Co's current EV-to-OCF is 7.60, which is 43% below median its own 10-year median of 13.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ShareHope Medicine Co stock overvalued right now?
Based on GuruFocus' analysis, ShareHope Medicine Co (ROCO:8403) is currently considered Possible Value Trap. The stock's GF Value™ is NT$28.99, compared to a current price of NT$18.95 — trading 34.6% below its estimated fair value. The current EV-to-OCF is 7.60, which is 43% below median its 10-year median of 13.42 and 0.1% below the Medical Distribution industry median of 7.61. ShareHope Medicine Co's overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For ShareHope Medicine Co (ROCO:8403), the current EV-to-OCF is 7.60 as of Sep. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ShareHope Medicine Co (ROCO:8403) Overvalued in 2026?
Based on GuruFocus' analysis, ShareHope Medicine Co stock appears to be undervalued.
The current stock price of NT$18.95 is trading 34.6% below its estimated GF Value™ of NT$28.99.
GuruFocus considers ShareHope Medicine Co to be Possible Value Trap.
Key valuation signals for ROCO:8403:
EV-to-OCF: 7.60 (43% below median its 10-year median of 13.42)
GF Value™: NT$28.99 vs. price of NT$18.95 (34.6% below fair value)
Industry Position: 0.1% below the Medical Distribution median (#64 of 122)
No single metric tells the full story. See the ROCO:8403 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ShareHope Medicine Co Ltd is engaged in wholesale and retail sales of medicines and hygiene materials, leasing of assets for medical institutions to undertake related medical services, and physical examinations for Taiwanese people and foreign labors, on-site medical support services, hemodialysis business management, ophthalmic medical management, clothing-related management services, manufacturing, processing and sales of various non-woven fabrics and management consulting for chain pharmacies in collaboration with medical institutions.
71GF Score
Get the complete analysis for ROCO:8403
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:8403 has been successfully added to your 
